Prot #BTTC09-01: NU 12C02:A Phase I-II trial Everolimus and Sorafenib in Patients with Recurrent High-Grade Gliomas

Raizer, Jeffrey J (PD/PI)

Neurology

Project: Research project

Status	Finished
Effective start/end date	1/7/13 → 1/7/23

Funding

University of Texas M. D. Anderson Cancer Center (Prot #BTTC09-01)
Bayer HealthCare Pharmaceuticals, Inc. and Novartis Pharmaceuticals Corporation (Prot #BTTC09-01)